Moreover, research has shown that BET inhibitors (JQ1 and I-BET151) exert anti-cancer effects in breast cancer by inducing ferroptosis, with NCOA3, as a coactivator, interacting with NR5A2 to counteract BETi-induced ferroptosis. This evidence concerns the gene NCOA3 and breast carcinoma.